Not original OP but had to weigh in on this.
At least the HCV reps KNOW that their drug is having major difficulties in the market and therefore strongly and logically expect subsequent headcount reductions soon after product launch is over. It has turned into a price war and we have an inferior product that cannot compete with Gilead's on any front.
What the hell does Metabolic see at their beck and call that would avoid their impending doom? Generics, major cardio risk baggage, huge revenue shortfalls with only more to come? Have heard Lupron being bantered about as a possible home for some of you.
That is NOT even close to being a safe haven for more then just a handful of Met reps.
Have you ever played musical chairs? When the music stops and you don't have a seat, you are OUT of the game.
Is AbbVie going to just allow Met reps to suck up salary and benefits indefinitely while your products are dying on the vine. Oh yeah, there is Synthroid, but do you REALLY believe they can keep your army around for a sample drop?
Puhhleese enlighten us as to your logic because maybe we are missing something. Is there a DEFINITE new product coming out SOON to redeem us all? Is there another major company in the works for our acquisition? (yeah that went real well with Shire, you mighta had a chance if that had ever happened)
What are we missing or do they medicate you with some agent that we need to be taking that will make us delusional and oh-so CONTENT also?